Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses M Rieckmann, M Delgobo, C Gaal, L Büchner, P Steinau, D Reshef, ... The Journal of clinical investigation 129 (11), 4922-4936, 2019 | 142 | 2019 |
CXCR4-directed theranostics in oncology and inflammation M Kircher, P Herhaus, M Schottelius, AK Buck, RA Werner, HJ Wester, ... Annals of nuclear medicine 32, 503-511, 2018 | 129 | 2018 |
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed multiple myeloma C Lapa, K Herrmann, A Schirbel, H Hänscheid, K Lückerath, ... Theranostics 7 (6), 1589, 2017 | 125 | 2017 |
Detection of cardiac amyloidosis with 18F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy M Kircher, S Ihne, J Brumberg, C Morbach, S Knop, KM Kortüm, S Störk, ... European journal of nuclear medicine and molecular imaging 46, 1407-1416, 2019 | 84 | 2019 |
Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI C Lapa, T Reiter, M Kircher, A Schirbel, RA Werner, T Pelzer, C Pizarro, ... Oncotarget 7 (47), 77807, 2016 | 84 | 2016 |
Feasibility of CXCR4-directed radioligand therapy in advanced diffuse large B-cell lymphoma C Lapa, H Hänscheid, M Kircher, A Schirbel, G Wunderlich, RA Werner, ... Journal of Nuclear Medicine 60 (1), 60-64, 2019 | 83 | 2019 |
The theranostic promise for Neuroendocrine Tumors in the late 2010s-Where do we stand, where do we go? RA Werner, A Weich, M Kircher, LB Solnes, MS Javadi, T Higuchi, ... Theranostics 8 (22), 6088, 2018 | 74 | 2018 |
Imaging inflammation in atherosclerosis with CXCR4-directed 68Ga-pentixafor PET/CT: correlation with 18F-FDG PET/CT M Kircher, J Tran-Gia, L Kemmer, X Zhang, A Schirbel, RA Werner, ... Journal of Nuclear Medicine 61 (5), 751-756, 2020 | 64 | 2020 |
CXCR4-directed imaging in solid tumors RA Werner, S Kircher, T Higuchi, M Kircher, A Schirbel, HJ Wester, ... Frontiers in Oncology 9, 770, 2019 | 59 | 2019 |
Imaging of C-X-C Motif Chemokine Receptor CXCR4 Expression After Myocardial Infarction With [68Ga]Pentixafor-PET/CT in Correlation With Cardiac MRI T Reiter, M Kircher, A Schirbel, RA Werner, S Kropf, G Ertl, AK Buck, ... JACC: Cardiovascular Imaging 11 (10), 1541-1543, 2018 | 59 | 2018 |
Novel noninvasive nuclear medicine imaging techniques for cardiac inflammation M Kircher, C Lapa Current cardiovascular imaging reports 10, 1-13, 2017 | 56 | 2017 |
Side effects of CXC-chemokine receptor 4–directed endoradiotherapy with pentixather before hematopoietic stem cell transplantation S Maurer, P Herhaus, R Lippenmeyer, H Hänscheid, M Kircher, ... Journal of Nuclear Medicine 60 (10), 1399-1405, 2019 | 52 | 2019 |
Improved primary staging of marginal-zone lymphoma by addition of CXCR4-directed PET/CT J Duell, F Krummenast, A Schirbel, P Klassen, S Samnick, ... Journal of Nuclear Medicine 62 (10), 1415-1421, 2021 | 45 | 2021 |
Comparison of 11C-choline and 11C-methionine PET/CT in multiple myeloma C Lapa, M Kircher, M Da Via, M Schreder, L Rasche, KM Kortüm, ... Clinical nuclear medicine 44 (8), 620-624, 2019 | 40 | 2019 |
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity–initial experience and comparison to [18F] FDG PET/CT and MRI C Linz, RC Brands, O Kertels, A Dierks, J Brumberg, E Gerhard-Hartmann, ... European journal of nuclear medicine and molecular imaging 48 (12), 3951-3960, 2021 | 37 | 2021 |
CXCR4-directed PET/CT in patients with newly diagnosed neuroendocrine carcinomas A Weich, RA Werner, AK Buck, PE Hartrampf, SE Serfling, M Scheurlen, ... Diagnostics 11 (4), 605, 2021 | 27 | 2021 |
Hexokinase-2 expression in 11C-Methionine–positive, 18F-FDG–negative multiple myeloma S Kircher, A Stolzenburg, KM Kortüm, M Kircher, M Da Via, S Samnick, ... Journal of Nuclear Medicine 60 (3), 348-352, 2019 | 23 | 2019 |
Investigation of spleen CXCR4 expression by [68Ga]Pentixafor PET in a cohort of 145 solid cancer patients R Lewis, S Habringer, M Kircher, M Hefter, CA Peuker, R Werner, ... EJNMMI research 11 (1), 77, 2021 | 20 | 2021 |
18F-FDG, 11C-methionine, and 68Ga-Pentixafor PET/CT in patients with smoldering multiple myeloma: imaging pattern and clinical features X Zhou, A Dierks, O Kertels, M Kircher, A Schirbel, S Samnick, AK Buck, ... Cancers 12 (8), 2333, 2020 | 19 | 2020 |
Clinical utility of different approaches for detection of late pseudoprogression in glioblastoma with O-(2-[18F] fluoroethyl)-L-tyrosine PET O Kertels, MI Mihovilovic, T Linsenmann, AF Kessler, J Tran-Gia, ... Clinical Nuclear Medicine 44 (9), 695-701, 2019 | 19 | 2019 |